Extracellular vesicle miRNAs promote the intestinal microenvironment by interacting with microbes in colitis

Qichen Shen1, Zhuizui Huang1, Lingyan Ma2

  • 1Department of Biotechnology, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.

Gut Microbes
|September 29, 2022
PubMed

Insights

Extracellular vesicles (EVs) and bacterial membrane vesicles (MVs) play key roles in inflammatory bowel disease (IBD). Specific microRNAs (miRNAs) within these vesicles, like miR-181b-5p and miR-200b-3p, show therapeutic potential for colitis by modulating host-microbe interactions.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • Inflammatory bowel disease (IBD) is a global health concern linked to gut microbial dysbiosis.
  • Extracellular vesicles (EVs) and outer membrane vesicles (OMVs) mediate host-microbe communication in the intestine.
  • The specific roles of EV-miRNAs and MVs in the pathogenesis and progression of colitis are not fully understood.

Purpose of the Study:

  • To investigate the alterations in colonic EVs-miRNAs in a dextran sulfate sodium (DSS)-induced colitis mouse model.
  • To explore the therapeutic potential of specific miRNAs and MVs in modulating host-microbe interactions and alleviating colitis.

Main Methods:

  • Induction of colitis in a mouse model using DSS.
  • Isolation and analysis of miRNAs from colonic EVs.
  • Investigating the effects of miR-181b-5p and miR-200b-3p on macrophage polarization and microbiota composition.
  • Assessing the therapeutic efficacy of fecal MVs and engineered BMVs in colitis models.

Main Results:

  • Significant alterations in miRNA profiles within colonic EVs were observed in colitis.
  • miR-181b-5p transplantation reduced inflammation by shifting macrophage polarization from M1 to M2.
  • miR-200b-3p interacted with bacteria, enhanced intestinal barrier integrity, and restored homeostasis.
  • Normal fecal MVs and colitis-derived BMVs (treated with miR-200b-3p) reversed microbiota dysbiosis and ameliorated colitis.

Conclusions:

  • A vesicle-mediated host-microbe interaction cycle in colitis is identified.
  • EVs-miRNAs and MVs represent promising therapeutic targets for IBD treatment.
  • This study offers novel strategies for managing colitis through modulation of the gut microbiome and host-vesicle communication.